Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1153.85x is 5776% below its 4-year average of -19.64x, near the low end of its 4-year range (-1153.85x–11.96x).
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -3.18x.
INTEREST COVERAGE RATIO
-1153.85x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
-15.71x
INTEREST COVERAGE RATIO AVG 5Y
-19.64x
INTEREST COVERAGE RATIO AVG 10Y
-17.90x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
-7245.09%
CURRENT VS 5Y AVG
-5775.53%
CURRENT VS 10Y AVG
-6347.42%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.64x
median of 462 covered companies
CURRENT VS SECTOR MEDIAN
-20340.21%
vs the sector median at left
Enlivex Therapeutics Ltd.
Market Cap
$5.98M
Interest Coverage Ratio
-1153.85x
TTM Avg
N/A
3Y Avg
-15.71x
5Y Avg
-19.64x
Market Cap
$6.07M
Interest Coverage Ratio
-438.08x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.10M
Interest Coverage Ratio
-3.98x
TTM Avg
2.35x
3Y Avg
2.44x
5Y Avg
2.44x
Market Cap
$5.77M
Interest Coverage Ratio
-310.21x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.72M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.60M
Interest Coverage Ratio
N/A
TTM Avg
2443.20x
3Y Avg
2443.20x
5Y Avg
2443.20x
Market Cap
$6.43M
Interest Coverage Ratio
-545.69x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Enlivex Therapeutics Ltd. (ENLV) | $5.98M | -1153.85x | N/A | -15.71x | -19.64x |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.07M | -438.08x | N/A | N/A | N/A |
| Scienture Holdings, Inc. (SCNX)vs › | $6.10M | -3.98x | 2.35x | 2.44x | 2.44x |
| Lucyd, Inc (LUCY)vs › | $5.85M | N/A | N/A | N/A | N/A |
| Femasys Inc. (FEMY)vs › | $6.16M | -9.30x | N/A | N/A | N/A |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.77M | -310.21x | N/A | N/A | N/A |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.72M | N/A | N/A | N/A | N/A |
| enVVeno Medical Corporation (NVNO)vs › | $5.60M | N/A | 2443.20x | 2443.20x | 2443.20x |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.43M | -545.69x | N/A | N/A | N/A |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.49M | -82777.81x | 11.97x | 11.97x | 11.97x |
Interest Coverage
-1153.8x
Debt/Equity
0.00
Current Ratio
119.39
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -3.18x |
| 2024-06-30 | -27.15x |
| 2023-09-30 | -16.80x |
| 2023-03-31 | -15.59x |
| 2022-12-31 | 11.96x |
| 2022-09-30 | -101.38x |
| 2022-06-30 | -1.45x |
| 2022-03-31 | -3.52x |
| 2020-09-30 | -8.78x |
| 2020-06-30 | -2.49x |
| 2020-03-31 | -948.00x |
| 2019-09-30 | -6.20x |
| 2019-06-30 | -6.42x |
| 2019-03-31 | -6.60x |
| 2018-12-31 | -4.71x |
| 2018-09-30 | -1241.00x |
| 2018-06-30 | -282.67x |
| 2018-03-31 | -76.13x |
| 2017-09-30 | -269.50x |
| 2014-06-30 | -556.00x |
| 2014-03-31 | -160.25x |
| 2013-09-30 | -64.00x |
| 2013-06-30 | -134.00x |
